Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Jamie N. Brown"'
Publikováno v:
Contemporary Clinical Trials Communications, Vol 14, Iss , Pp - (2019)
Background: An investigational drug service (IDS) has a foundational role in ensuring the safe and efficient management of investigational drugs. The objective of this assessment is to determine economic value of an IDS within a Veterans Affairs heal
Externí odkaz:
https://doaj.org/article/c39039876e054242b005a88177b1694f
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 8 (2015)
Objective: To describe and evaluate the available evidence assessing the role of tacrolimus in the management of patients with myasthenia gravis (MG). Data sources: A literature search of MEDLINE (1946 to September 2014) and EMBASE (1947 to September
Externí odkaz:
https://doaj.org/article/9af6b2e167084d058107026661da1739
Autor:
Jamie N. Brown, Nicole Panosh
Publikováno v:
Health Services Insights, Vol 2 (2009)
Objective To review the efficacy of omega-3 fatty acids in the treatment of attention deficit/hyperactivity disorder (ADHD). Data Souces Literature was accessed via MEDLINE (1950–February 2009) and International Pharmaceutical Abstracts (1960–200
Externí odkaz:
https://doaj.org/article/8946b1a9225a4b48846923a7fbc82822
Autor:
Sarah Gonzales, Olaoluwa O Okusaga, J Corey Reuteman-Fowler, Megan M Oakes, Jamie N Brown, Scott Moore, Allison A Lewinski, Cristin Rodriguez, Norma Moncayo, Valerie A Smith, Shauna Malone, Justine List, Raymond Y Cho, Amy S Jeffreys, Hayden B Bosworth
Publikováno v:
JMIR Formative Research, Vol 6, Iss 12, p e34893 (2022)
BackgroundSuboptimal medication adherence is a significant problem for patients with serious mental illness. Measuring medication adherence through subjective and objective measures can be challenging, time-consuming, and inaccurate. ObjectiveThe pr
Externí odkaz:
https://doaj.org/article/8ee0892eaa5c4f9baaa6017d8ecf5b1d
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 38
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7eef78611b179a262de6a9a07a11ff3
https://doi.org/10.1002/hup.2864
https://doi.org/10.1002/hup.2864
Publikováno v:
Journal of Critical Care. 59:1-5
Purpose To assess the efficacy and safety of suvorexant for the prevention of delirium during acute hospitalization. Materials and methods Pubmed (1946 to December 2019) and Embase (1947 to December 2019) were queried using the search term combinatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b466ec9a63d6d4d031bb5f7dd5dfbbb
https://doi.org/10.1016/j.jcrc.2020.05.006
https://doi.org/10.1016/j.jcrc.2020.05.006
Autor:
Jamie N. Brown, Anna M. Hu
Publikováno v:
Clinical Rheumatology. 39:3287-3294
Patients with chronic kidney disease (CKD) are more likely to develop hyperuricemia and gout. Allopurinol and febuxostat are the most commonly used urate-lowering therapies with established safety and efficacy in CKD patients. The objective of the sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00b1df81427de9ac307ef7a1cdd558e3
https://doi.org/10.1007/s10067-020-05079-3
https://doi.org/10.1007/s10067-020-05079-3
Publikováno v:
Infectious Diseases. 52:381-390
Background: Helicobacter pylori is one of the most common chronic infections and is a leading cause of gastric cancer. There are currently several short-course treatment options available f...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02925d611dd42550887deabb3ab4f9b3
https://doi.org/10.1080/23744235.2019.1708454
https://doi.org/10.1080/23744235.2019.1708454
Publikováno v:
Clinical Genitourinary Cancer. 17:419-424
Pazopanib is a protein tyrosine kinase inhibitor that limits tumor growth through angiogenesis inhibition. The use of other protein tyrosine kinase inhibitors, specifically sunitinib, within non-clear cell renal cell carcinoma (nccRCC) has led to inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d81158d0e8dcf09e794842e607a8ff5
https://doi.org/10.1016/j.clgc.2019.09.001
https://doi.org/10.1016/j.clgc.2019.09.001
Autor:
Sarah Gonzales, Olaoluwa O. Okusaga, J. Corey Reuteman-Fowler, Megan M. Oakes, Jamie N. Brown, Scott Moore, Allison A. Lewinski, Cristin Rodriguez, Norma Moncayo, Valerie A. Smith, Shauna Malone, Justine List, Raymond Y. Cho, Amy S. Jeffreys, Hayden B. Bosworth
BACKGROUND Suboptimal medication adherence is a significant problem for patients with serious mental illness (SMI). Measuring medication adherence through subjective and objective measures can be challenging, time consuming and inaccurate. OBJECTIVE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de2d8073988fc1e91a613af0dfb89788
https://doi.org/10.2196/preprints.34893
https://doi.org/10.2196/preprints.34893
